Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab

Enno Schmidt; Sandrine Benoit; Eva Bettina Bröcker; Detlef Zillikens; Matthias Goebeler

doi:10.1001/archderm.142.2.147

Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab

Enno Schmidt, Sandrine Benoit, Eva Bettina Bröcker, Detlef Zillikens, Matthias Goebeler^*

^*Corresponding author for this work

Original language	English
Journal	Archives of Dermatology
Volume	142
Issue number	2
Pages (from-to)	147-150
Number of pages	4
ISSN	0003-987X
DOIs	https://doi.org/10.1001/archderm.142.2.147
Publication status	Published - 02.2006

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/archderm.142.2.147

Cite this

@article{f2fa48d8ffbd453cb16ff41159b2e1b2,

title = "Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab",

author = "Enno Schmidt and Sandrine Benoit and Br{\"o}cker, {Eva Bettina} and Detlef Zillikens and Matthias Goebeler",

year = "2006",

month = feb,

doi = "10.1001/archderm.142.2.147",

language = "English",

volume = "142",

pages = "147--150",

journal = "Archives of Dermatology",

issn = "0003-987X",

number = "2",

}

TY - JOUR

T1 - Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab

AU - Schmidt, Enno

AU - Benoit, Sandrine

AU - Bröcker, Eva Bettina

AU - Zillikens, Detlef

AU - Goebeler, Matthias

PY - 2006/2

Y1 - 2006/2

UR - http://www.scopus.com/inward/record.url?scp=33244480130&partnerID=8YFLogxK

U2 - 10.1001/archderm.142.2.147

DO - 10.1001/archderm.142.2.147

M3 - Journal articles

C2 - 16490841

AN - SCOPUS:33244480130

SN - 0003-987X

VL - 142

SP - 147

EP - 150

JO - Archives of Dermatology

JF - Archives of Dermatology

IS - 2

ER -

Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab

Research Areas and Centers

UN SDGs

Access to Document

Other files and links

Cite this